Published on February 28th, 2020 by Bob Ciura
Value investing is a broad term, and can mean different things to different investors. Value investors typically look for cheap stocks, although
News
Clovis Oncology Announces Availability and Reimbursement for Rubraca® (rucaparib) Tablets for Women with Relapsed Ovarian Cancer in Spain
Clovis Oncology, Inc. (NASDAQ: CLVS) today announced that Rubraca® (rucaparib) is now available and reimbursed in Spain following the Spanish Interministerial Commission on Prices of Medicines and
SES Announces Next Phase of Strategic Transformation
SES is launching a comprehensive programme to position itself for future growth and deliver maximum value to current and future customers and stakeholders.
This press release features multimedia
SES: Full Year 2019 Results
SES S.A. today announced financial results for the year ended 31 December 2019 with results in line with SES’ financial outlook, including a second successive year of revenue growth in SES
Essex Property Trust Updates Timing of the 2020 Citigroup Global Property CEO Conference
Essex Property Trust, Inc. (NYSE:ESS) announced today that the date and time of the roundtable presentation at the 2020 Citigroup Global Property CEO Conference in Hollywood, Florida has changed
NuStar to Participate in the Barclays Select Series: Midstream & Infrastructure Corporate Access Days
NuStar Energy L.P. (NYSE: NS) announced today that Brad Barron, President and Chief Executive Officer; Danny Oliver, Executive Vice President of Business Development & Engineering; Amy Perry
NuStar Energy L.P.’s 2019 Schedule K-1 Tax Packages Now Available
NuStar Energy L.P. (NYSE: NS) today announced that the 2019 tax packages, which include the Schedule K-1’s for Series A, Series B and Series C preferred units and common units, are available online
El Paso Electric Announces Quarterly Dividend
The Board of Directors of El Paso Electric Company (NYSE:EE) has declared a regular quarterly cash dividend on its common stock of $0.385 per share. The dividend was declared on February 28, 2020
Groupon to Participate in the UBS Global Consumer and Retail Conference
Groupon, Inc. (NASDAQ: GRPN), a global leader in local commerce, today announced that Rich Williams, Chief Executive Officer, and Melissa Thomas, Chief Financial Officer, will attend the UBS Global
Western Union to Present at the Wolfe Research FinTech Forum
The Western Union Company (NYSE: WU), a global leader in cross-border, cross-currency money movement and payments, today announced that the Company will present at the Wolfe Research FinTech Forum
Nutrien Files 2019 Annual Disclosures
Nutrien Ltd. (Nutrien) (NYSE, TSX: NTR) today announced that its 2019 Annual Report, including Management’s Discussion and Analysis and Audited Consolidated Financial Statements, as well as its
Aptorum Group Announces Closing of $10 Million Registered Direct Offering of Class A Ordinary Shares and Warrants
Aptorum Group Limited (NASDAQ:APM) (“Aptorum Group”), a biopharmaceutical company focused on the development of novel therapeutics to address global unmet medical needs, today announced the closing
United Bankshares, Inc. to Present at Raymond James 41st Annual Institutional Investors Conference
United Bankshares, Inc. (NASDAQ: UBSI), will be presenting at the Raymond James 41st Annual Institutional Investors Conference on Tuesday, March 3, 2020 at 8:05 a.m. (Eastern), at the JW Marriott
Berman Tabacco Files Securities Class Action Lawsuit Against Sterling Bancorp, Inc. (SBT)
On February 26, 2020, Berman Tabacco (www.bermantabacco.com), a national law firm representing investors, filed a class action lawsuit for violations of the federal securities laws against Sterling
Nanobiotix 2019 Q4 and Annual Revenues
Regulatory News:
NANOBIOTIX (Paris:NANO) (Euronext : NANO – ISIN : FR0011341205 – the ‘‘Company’’), a late clinical-stage nanomedicine company pioneering new approaches to the treatment of
Monthly Dividend Stock In Focus: Whitestone REIT
Updated on February 28th, 2020 by Josh Arnold
Real Estate Investment Trusts are popular investments among income investors, and for obvious reasons. They are required to pass along the vast
Insight Honors Companies Successfully Transforming Through Tech at Evolve 2020 Event
Insight Enterprises (NASDAQ:NSIT), the global integrator of Insight Intelligent Technology Solutions™ for organizations of all sizes, honored companies that are achieving success through digital
Craft Brew Alliance to Report Fourth Quarter and Full-Year 2019 Financial Results on March 11, 2020
Craft Brew Alliance, Inc. (“CBA”) (Nasdaq: BREW), a leading craft brewing company, today announced it will report fourth quarter and full-year 2019 financial results on Wednesday, March 11, 2020
Michelle M. MacKay Will Join Cushman & Wakefield as Chief Operating Officer
Cushman & Wakefield (NYSE: CWK) announced today that Michelle M. MacKay will join the firm as Chief Operating Officer (COO), stepping down from her role on the firm’s Board of Directors, effective
AgeX Therapeutics Researchers Publish Paper on the Age Reprogramming of Super-Centenarian Cells
AgeX Therapeutics, Inc. (“AgeX”; NYSE American: AGE), a biotechnology company focused on developing therapeutics for human aging and regeneration, announced a new paper co-authored by two AgeX
Puma Biotechnology to Present at Cowen’s Annual Health Care Conference
Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that Alan H. Auerbach, Chairman, Chief Executive Officer, President and Founder of Puma, will provide an overview of
Agilent Technologies Announces Webcasts for Investment Community
Agilent Technologies Inc. (NYSE: A) today announced the following webcasts for the investment community.
40th Annual Cowen And Company Healthcare Conference
Tuesday, March 3, 2020 at 10:00 a.m
Antibe Therapeutics Announces Enrollment of Last Patient in Phase 2B Dose-ranging, Efficacy Study of Lead Drug, ATB-346
Antibe Therapeutics Inc. ("Antibe" or the “Company”) (TSXV: ATE, OTCQB: ATBPF), a leader in developing safer, non-addictive therapeutics for pain and inflammation, is pleased to announce that the
Sangamo Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results
Sangamo Therapeutics, Inc. (NASDAQ: SGMO), a genomic medicine company, today reported fourth quarter and full year 2019 financial results and recent business highlights.
“This quarter marked an